Marco Severgnini

This paper develops a nanoplatform using red blood cell-derived extracellular vesicles to deliver Cetuximab and cisplatin, enhancing cancer cell killing and reducing toxicity in triple-negative breast cancer.

This paper compares four 16S rRNA reference databases (Greengenes, SILVA, RDP, NCBI) across four microbiota datasets, finding that while alpha- and beta-diversity vary, the ability to detect experimental group differences remains consistent across databases.

This study investigates the effects of HDAC inhibitors in RSTS models, showing molecular rescue and microbiota changes, and highlights the role of gut microbiota in chromatinopathy.

The paper identifies antenatal microbial colonisation in rodent and human foetuses using sequencing and culture methods, showing microbial presence in intestinal tissues and amniotic fluid.